跳至主要内容
临床试验/NCT03413982
NCT03413982招募中不适用

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年11月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Blood, urine and tissue characteristics of bladder cancer patients

研究概览

简要总结

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
  • Patients can participate in any additional research studies during the patients' participation within this protocol.

排除标准

  • Patients who do not have presumed bladder cancer will not be eligible

研究组 & 干预措施

BC Patients

Patients with bladder cancer. This registry involves no intervention. Blood, urine, and tissue samples will be collected to be used for research.

干预措施: Registry (Other)

结局指标

主要结局

Blood, urine and tissue characteristics of bladder cancer patients

时间窗: 24 months

Samples will be collected over a 24 month period for patients to build a biorepository for future research on how they are related to tumor development, recurrence and survival.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验